A bill to prohibit contracting with certain biotechnology providers.

This bill prohibits U.S. federal agencies from contracting for or obtaining "covered biotechnology equipment or services" from entities designated as "biotechnology companies of concern," primarily targeting Chinese-owned or controlled firms like Wuxi AppTec, BGI Group, and MGI Group. It applies to all executive agencies, banning purchases, contracts, or use of grant/loan funds for such equipment or services, with exceptions for intelligence activities, overseas health care for U.S. personnel, and commercially available genetic data. Agencies may seek limited waivers (up to 180 days, extendable once) for specific cases like overseas health care, but must get OMB approval and notify Congress. The bill requires the Secretary of Defense to evaluate Chinese biotech entities within 90 days and mandates new regulations within 180-270 days to implement the restrictions.